Lisata Therapeutics (LSTA) Return on Equity (2016 - 2025)
Lisata Therapeutics' Return on Equity history spans 12 years, with the latest figure at 1.05% for Q4 2025.
- For Q4 2025, Return on Equity fell 41.0% year-over-year to 1.05%; the TTM value through Dec 2025 reached 1.05%, down 41.0%, while the annual FY2025 figure was 0.76%, 24.0% down from the prior year.
- Return on Equity reached 1.05% in Q4 2025 per LSTA's latest filing, down from 0.96% in the prior quarter.
- In the past five years, Return on Equity ranged from a high of 0.34% in Q2 2023 to a low of 1.05% in Q4 2025.
- Average Return on Equity over 3 years is 0.61%, with a median of 0.55% recorded in 2024.
- Peak YoY movement for Return on Equity: rose 4bps in 2024, then tumbled -41bps in 2025.
- A 3-year view of Return on Equity shows it stood at 0.41% in 2023, then tumbled by -54bps to 0.64% in 2024, then crashed by -64bps to 1.05% in 2025.
- Per Business Quant, the three most recent readings for LSTA's Return on Equity are 1.05% (Q4 2025), 0.96% (Q3 2025), and 0.82% (Q2 2025).